ZTS - Zoetis (ZTS) Drops on Report that Arthritis Drugs May Sicken Pets – Hagens Berman | Benzinga

SAN FRANCISCO, April 12, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Zoetis Inc. (NYSE:ZTS) investors who suffered substantial losses to submit your losses now and persons with knowledge who may be able to assist the investigation to contact its attorneys.

Visit: www.hbsslaw.com/investor-fraud/ZTS
Contact An Attorney Now: ZTS@hbsslaw.com
                                                   844-916-0895

Zoetis Inc. (ZTS) Investigation:

On Apr. 12, 2024, the price of Zoetis shares fell $12.75, or nearly 8%, after the WSJ published "What Killed Their Pets? Owners Blame Meds, but Vets Aren't Sure."

The WSJ's article focuses on Zoetis' Librela and Solensia, therapies intended to relieve painful canine and feline osteoarthritis, respectively. In the past, the products have been important ...

ZTS) Drops on Report that Arthritis Drugs May Sicken Pets – Hagens Berman>Full story available on Benzinga.com